Discontinuation of long-term adalimumab treatment in patients with juvenile idiopathic arthritis-associated uveitis
Crossref DOI link: https://doi.org/10.1007/s00417-016-3497-5
Published Online: 2016-09-30
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Breitbach, Marc
Tappeiner, Christoph
Böhm, Michael R. R.
Zurek-Imhoff, Beatrix
Heinz, Carsten
Thanos, Solon
Ganser, Gerd
Heiligenhaus, Arnd
License valid from 2016-09-30